Montag & Associates’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-375
Closed -$19.2K 1001
2024
Q3
$19.2K Hold
375
﹤0.01% 732
2024
Q2
$23.7K Sell
375
-848
-69% -$50.9K ﹤0.01% 689
2024
Q1
$81K Hold
1,223
﹤0.01% 518
2023
Q4
$120K Hold
1,223
0.01% 452
2023
Q3
$98K Hold
1,223
0.01% 461
2023
Q2
$98.8K Hold
1,223
0.01% 476
2023
Q1
$149K Hold
1,223
0.01% 420
2022
Q4
$163K Hold
1,223
0.01% 397
2022
Q3
$137K Hold
1,223
0.01% 400
2022
Q2
$166K Sell
1,223
-2
-0.2% -$301 0.01% 380
2022
Q1
$204K Hold
1,225
0.01% 387
2021
Q4
$219K Hold
1,225
0.01% 379
2021
Q3
$217K Hold
1,225
0.01% 371
2021
Q2
$197K Hold
1,225
0.01% 389
2021
Q1
$183K Hold
1,225
0.01% 397
2020
Q4
$121K Buy
+1,225
New +$122K 0.01% 436

Other funds holding CNXC

Montag & Associates's CNXC Position: Q4 2024 in Review

Montag & Associates sold out of Concentrix (CNXC) in Q4 2024, closing a stake of 375 shares — an estimated $19.2K sold.

Montag & Associates first reported a position in CNXC in Q4 2020 and held it in 16 quarters. The position peaked at $219K in Q4 2021. 291 funds tracked by Wall St. Rank hold CNXC as of Q4 2024.

  • Montag & Associates reported no remaining Concentrix position as of Q4 2024 after selling out during the quarter.
  • Montag & Associates sold 375 Concentrix shares in Q4 2024, an estimated $19.2K.
  • Montag & Associates first reported a position in Concentrix in Q4 2020 and held it in 16 quarters.
  • Montag & Associates's Concentrix position peaked at $219K in Q4 2021.
  • 291 funds tracked by Wall St. Rank held Concentrix as of Q4 2024.

Based on Montag & Associates's 13F filing for Q4 2024, filed 30 Jan 2025.